Совершенствование лечения центральной серозной хориоретинопатии

Туйчибаева Д.М., Ф. М. Урманова

Передовая Офтальмология · 2025-yil

Annotatsiya

Relevance. Central serous chorioretinopathy (CSC) is a chronic disease characterized by idiopathic serous neurosensory retinal detachment and/or retinal pigment epithelium (RPE) detachment, with changes, most often limited to the macula and associated with impaired barrier, transport, pumping, and cytokine-producing functions of the RPE, increased permeability of Bruch's membrane, and fluid seepage from the choriocapillaries through the RPE into the subretinal space. Purpose of the study. To evaluate the efficacy and safety of application of subthreshold micropulse laser therapy with the wavelength of 577 nm in the treatment of central serous chorioretinopathy. Materials and methods. 23 patients (23 eyes) were included in the study. The patients' age ranged from 41 to 58 years. Among the patients there were 10 women and 13 men. Laser treatment was performed on the “IRIDEX IQ 577” (IRIDEX Corporation, Mountain View, USA) with yellow (577 nm) wavelength of radiation, which allows to work both in micropulse and continuous modes. Results and conclusion. Positive dynamics was observed in all cases during the follow-up, by the end of the follow-up period all patients noted improvement of vision, reduction of distortions. After laser treatment in 35.7% of cases of the main group there was a complete adhesion of serous ONE of the retinae, while in 64.3% of cases subretinal fluid remained. In the control group after focal LCS, complete resorption of ONE was detected in the majority of cases, while in 36% of cases the process persisted. By the period of 12 months the disease recurrence was detected in 8% of cases, and ONE adherence was determined in 92%. Micropulse laserexposure has shown its effectiveness in the treatment of long-term and recurrent chronic central serous chorioretinopathy and allows to perform multiple, repeated laser interventions without laser-induced damage.

Maqola ma’lumotlari
MualliflarТуйчибаева Д.М., Ф. М. Урманова
JurnalПередовая Офтальмология
NashriyotБухоро давлат тиббиёт институти
ISSN2181-4236, 2181-4244
Nashr sanasi2025-05-21
Jild11
Son5
Betlar62-66
TilRus
Ilmiy sohaTibbiyot
DOI10.57231/j.ao.2024.11.5.014
Indeksga qo‘shilgan2026-09-02

DOI: 10.57231/j.ao.2024.11.5.014 · Maqolaning asl sahifasi · PDF

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAТуйчибаева Д.М., & Ф. М. Урманова (2025). СОВЕРШЕНСТВОВАНИЕ ЛЕЧЕНИЯ ЦЕНТРАЛЬНОЙ СЕРОЗНОЙ ХОРИОРЕТИНОПАТИИ. Передовая Офтальмология, 11(5), 62-66. https://doi.org/10.57231/j.ao.2024.11.5.014
GOST (OAK)Туйчибаева Д.М., Ф. М. Урманова СОВЕРШЕНСТВОВАНИЕ ЛЕЧЕНИЯ ЦЕНТРАЛЬНОЙ СЕРОЗНОЙ ХОРИОРЕТИНОПАТИИ // Передовая Офтальмология. – 2025. – T. 11, № 5. – С. 62-66. – DOI: 10.57231/j.ao.2024.11.5.014.
MLAТуйчибаева Д.М., and Ф. М. Урманова. “СОВЕРШЕНСТВОВАНИЕ ЛЕЧЕНИЯ ЦЕНТРАЛЬНОЙ СЕРОЗНОЙ ХОРИОРЕТИНОПАТИИ.” Передовая Офтальмология, 11(5), 62-66, 2025. https://doi.org/10.57231/j.ao.2024.11.5.014
ChicagoТуйчибаева Д.М., and Ф. М. Урманова. “СОВЕРШЕНСТВОВАНИЕ ЛЕЧЕНИЯ ЦЕНТРАЛЬНОЙ СЕРОЗНОЙ ХОРИОРЕТИНОПАТИИ.” Передовая Офтальмология, 11(5), 62-66 (2025). https://doi.org/10.57231/j.ao.2024.11.5.014
HarvardТуйчибаева Д.М., and Ф. М. Урманова (2025) ‘СОВЕРШЕНСТВОВАНИЕ ЛЕЧЕНИЯ ЦЕНТРАЛЬНОЙ СЕРОЗНОЙ ХОРИОРЕТИНОПАТИИ’, Передовая Офтальмология, 11(5), 62-66. https://doi.org/10.57231/j.ao.2024.11.5.014
BibTeX
@article{article2025,
  title = {СОВЕРШЕНСТВОВАНИЕ ЛЕЧЕНИЯ ЦЕНТРАЛЬНОЙ СЕРОЗНОЙ ХОРИОРЕТИНОПАТИИ},
  author = {Туйчибаева Д.М. and Ф. М. Урманова},
  journal = {Передовая Офтальмология},
  year = {2025},
  volume = {11},
  number = {5},
  pages = {62-66},
  doi = {10.57231/j.ao.2024.11.5.014},
  url = {https://doi.org/10.57231/j.ao.2024.11.5.014}
}

Boshqa maqola uchun iqtibos tayyorlash

Передовая Офтальмология jurnalidan boshqa maqolalar

Передовая Офтальмология — barcha maqolalar · 2025-yil arxivi

Туйчибаева Д.М. — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari